Peer Review reports

From: Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study

Original Submission
24 Sep 2020 Submitted Original manuscript
9 Dec 2020 Author responded Author comments - Daniel C Beachler
9 Nov 2020 Reviewed Reviewer Report
23 Nov 2020 Reviewed Reviewer Report
24 Nov 2020 Reviewed Reviewer Report
Resubmission - Version 2
9 Dec 2020 Submitted Manuscript version 2
23 Dec 2020 Author responded Author comments - Daniel C Beachler
16 Dec 2020 Reviewed Reviewer Report
Resubmission - Version 3
23 Dec 2020 Submitted Manuscript version 3
Publishing
5 Jan 2021 Editorially accepted
25 Jan 2021 Article published 10.1186/s12885-021-07790-z

You can find further information about peer review here.

Back to article page